nodes	percent_of_prediction	percent_of_DWPC	metapath
Piroxicam—osteoarthritis—Prednisone—hematologic cancer	0.366	1	CpDpCtD
Piroxicam—ALB—hematologic cancer	0.101	1	CbGaD
Piroxicam—PTGS2—Lenalidomide—hematologic cancer	0.0516	0.108	CbGbCtD
Piroxicam—PTGS2—Thalidomide—hematologic cancer	0.0275	0.0577	CbGbCtD
Piroxicam—PTGS1—Bortezomib—hematologic cancer	0.0267	0.0559	CbGbCtD
Piroxicam—SLC22A8—Mercaptopurine—hematologic cancer	0.0249	0.0521	CbGbCtD
Piroxicam—PTGS1—Thalidomide—hematologic cancer	0.0232	0.0487	CbGbCtD
Piroxicam—PTGS1—Ifosfamide—hematologic cancer	0.0205	0.0429	CbGbCtD
Piroxicam—PTGS1—Imatinib—hematologic cancer	0.0196	0.041	CbGbCtD
Piroxicam—PTGS2—Triamcinolone—hematologic cancer	0.0191	0.04	CbGbCtD
Piroxicam—CYP2C9—Bexarotene—hematologic cancer	0.0175	0.0367	CbGbCtD
Piroxicam—PTGS2—Betamethasone—hematologic cancer	0.0164	0.0343	CbGbCtD
Piroxicam—CYP2C8—Bortezomib—hematologic cancer	0.0154	0.0323	CbGbCtD
Piroxicam—ALB—Imatinib—hematologic cancer	0.0146	0.0306	CbGbCtD
Piroxicam—CYP2C9—Idarubicin—hematologic cancer	0.0145	0.0304	CbGbCtD
Piroxicam—SLC22A11—Methotrexate—hematologic cancer	0.014	0.0293	CbGbCtD
Piroxicam—CYP2C8—Ifosfamide—hematologic cancer	0.0118	0.0247	CbGbCtD
Piroxicam—PTGS2—Cisplatin—hematologic cancer	0.0118	0.0247	CbGbCtD
Piroxicam—PTGS2—Etoposide—hematologic cancer	0.0116	0.0243	CbGbCtD
Piroxicam—CYP2C9—Bortezomib—hematologic cancer	0.0107	0.0225	CbGbCtD
Piroxicam—CYP2C8—Nilotinib—hematologic cancer	0.0103	0.0215	CbGbCtD
Piroxicam—PTGS1—Etoposide—hematologic cancer	0.00978	0.0205	CbGbCtD
Piroxicam—ALB—Prednisone—hematologic cancer	0.00962	0.0202	CbGbCtD
Piroxicam—PTGS2—Dexamethasone—hematologic cancer	0.00952	0.02	CbGbCtD
Piroxicam—CYP2C9—Thalidomide—hematologic cancer	0.00936	0.0196	CbGbCtD
Piroxicam—ALB—Irinotecan—hematologic cancer	0.00912	0.0191	CbGbCtD
Piroxicam—CYP2C9—Teniposide—hematologic cancer	0.00893	0.0187	CbGbCtD
Piroxicam—CYP2C9—Ifosfamide—hematologic cancer	0.00824	0.0173	CbGbCtD
Piroxicam—SLC22A8—Methotrexate—hematologic cancer	0.00813	0.017	CbGbCtD
Piroxicam—CYP2C9—Imatinib—hematologic cancer	0.00787	0.0165	CbGbCtD
Piroxicam—CYP2C9—Nilotinib—hematologic cancer	0.00715	0.015	CbGbCtD
Piroxicam—SLC22A6—Methotrexate—hematologic cancer	0.00567	0.0119	CbGbCtD
Piroxicam—CYP2C8—Etoposide—hematologic cancer	0.00564	0.0118	CbGbCtD
Piroxicam—ALB—Methotrexate—hematologic cancer	0.00483	0.0101	CbGbCtD
Piroxicam—CYP2C8—Dexamethasone—hematologic cancer	0.00464	0.00972	CbGbCtD
Piroxicam—CYP2C9—Cisplatin—hematologic cancer	0.00401	0.00839	CbGbCtD
Piroxicam—CYP2C9—Dexamethasone—hematologic cancer	0.00324	0.00678	CbGbCtD
Piroxicam—PTGS2—ovarian follicle—hematologic cancer	0.00233	0.341	CbGeAlD
Piroxicam—SLC22A8—hematopoietic system—hematologic cancer	0.000496	0.0725	CbGeAlD
Piroxicam—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000383	0.209	CbGdCrCtD
Piroxicam—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000383	0.209	CbGdCrCtD
Piroxicam—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000374	0.205	CbGdCrCtD
Piroxicam—CYP2C8—hematopoietic system—hematologic cancer	0.000363	0.053	CbGeAlD
Piroxicam—SLC22A8—blood—hematologic cancer	0.000329	0.048	CbGeAlD
Piroxicam—CYP2C9—hematopoietic system—hematologic cancer	0.000323	0.0471	CbGeAlD
Piroxicam—PTGS1—hematopoietic system—hematologic cancer	0.000295	0.043	CbGeAlD
Piroxicam—ALB—testis—hematologic cancer	0.000283	0.0414	CbGeAlD
Piroxicam—PTGS2—hematopoietic system—hematologic cancer	0.000282	0.0411	CbGeAlD
Piroxicam—CYP2C8—blood—hematologic cancer	0.000241	0.0351	CbGeAlD
Piroxicam—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000231	0.126	CbGdCrCtD
Piroxicam—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000231	0.126	CbGdCrCtD
Piroxicam—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000226	0.124	CbGdCrCtD
Piroxicam—CYP2C9—blood—hematologic cancer	0.000214	0.0312	CbGeAlD
Piroxicam—ALB—lymph node—hematologic cancer	0.000205	0.03	CbGeAlD
Piroxicam—CYP2C8—testis—hematologic cancer	0.000199	0.0291	CbGeAlD
Piroxicam—PTGS1—blood—hematologic cancer	0.000195	0.0285	CbGeAlD
Piroxicam—PTGS2—blood—hematologic cancer	0.000187	0.0272	CbGeAlD
Piroxicam—PTGS2—bone marrow—hematologic cancer	0.00018	0.0264	CbGeAlD
Piroxicam—PTGS1—lung—hematologic cancer	0.000171	0.025	CbGeAlD
Piroxicam—PTGS2—lung—hematologic cancer	0.000164	0.0239	CbGeAlD
Piroxicam—PTGS1—testis—hematologic cancer	0.000161	0.0236	CbGeAlD
Piroxicam—PTGS1—lymph node—hematologic cancer	0.000117	0.0171	CbGeAlD
Piroxicam—PTGS2—lymph node—hematologic cancer	0.000112	0.0163	CbGeAlD
Piroxicam—CYP2C8—Metabolism—SLC22A1—hematologic cancer	7.12e-06	0.000152	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CRABP1—hematologic cancer	7.12e-06	0.000152	CbGpPWpGaD
Piroxicam—ALB—Metabolism—SLC22A1—hematologic cancer	7.08e-06	0.000151	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CRABP1—hematologic cancer	7.08e-06	0.000151	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.03e-06	0.00015	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ARNTL—hematologic cancer	7e-06	0.000149	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PIK3CG—hematologic cancer	7e-06	0.000149	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ALOX5—hematologic cancer	6.94e-06	0.000148	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.92e-06	0.000147	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HSP90AA1—hematologic cancer	6.92e-06	0.000147	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ALOX5—hematologic cancer	6.9e-06	0.000147	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PTPN11—hematologic cancer	6.88e-06	0.000146	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.84e-06	0.000146	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CA9—hematologic cancer	6.81e-06	0.000145	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ACP5—hematologic cancer	6.81e-06	0.000145	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—NCOR2—hematologic cancer	6.73e-06	0.000143	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—NUP98—hematologic cancer	6.72e-06	0.000143	CbGpPWpGaD
Piroxicam—ALB—Metabolism—NUP98—hematologic cancer	6.68e-06	0.000142	CbGpPWpGaD
Piroxicam—PTGS2—Disease—STAT1—hematologic cancer	6.67e-06	0.000142	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.57e-06	0.00014	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.54e-06	0.000139	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—NCOA3—hematologic cancer	6.52e-06	0.000139	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ADCY7—hematologic cancer	6.52e-06	0.000139	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—CREBBP—hematologic cancer	6.49e-06	0.000138	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ADCY7—hematologic cancer	6.49e-06	0.000138	CbGpPWpGaD
Piroxicam—ALB—Metabolism—NCOA3—hematologic cancer	6.49e-06	0.000138	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—NUP214—hematologic cancer	6.48e-06	0.000138	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GSTP1—hematologic cancer	6.48e-06	0.000138	CbGpPWpGaD
Piroxicam—ALB—Metabolism—NUP214—hematologic cancer	6.44e-06	0.000137	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.41e-06	0.000136	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—IDH1—hematologic cancer	6.41e-06	0.000136	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.37e-06	0.000136	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ABCG2—hematologic cancer	6.34e-06	0.000135	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—MTR—hematologic cancer	6.34e-06	0.000135	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	6.34e-06	0.000135	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—TXN—hematologic cancer	6.33e-06	0.000135	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GSTO1—hematologic cancer	6.33e-06	0.000135	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ABCC3—hematologic cancer	6.33e-06	0.000135	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ABCG2—hematologic cancer	6.31e-06	0.000134	CbGpPWpGaD
Piroxicam—ALB—Metabolism—MTR—hematologic cancer	6.31e-06	0.000134	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.27e-06	0.000133	CbGpPWpGaD
Piroxicam—PTGS2—Disease—GRB2—hematologic cancer	6.24e-06	0.000133	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PDGFA—hematologic cancer	6.23e-06	0.000133	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ENO2—hematologic cancer	6.22e-06	0.000132	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SPHK1—hematologic cancer	6.2e-06	0.000132	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ENO2—hematologic cancer	6.19e-06	0.000132	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CD44—hematologic cancer	6.16e-06	0.000131	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—NQO1—hematologic cancer	6.16e-06	0.000131	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PIK3CD—hematologic cancer	6.15e-06	0.000131	CbGpPWpGaD
Piroxicam—PTGS2—Disease—KITLG—hematologic cancer	6.14e-06	0.000131	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ABCB1—hematologic cancer	6.13e-06	0.000131	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.04e-06	0.000129	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GSTT1—hematologic cancer	6.04e-06	0.000128	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GSTT1—hematologic cancer	6e-06	0.000128	CbGpPWpGaD
Piroxicam—PTGS2—Disease—STAT5A—hematologic cancer	6e-06	0.000128	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5.96e-06	0.000127	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—NCOR1—hematologic cancer	5.95e-06	0.000127	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—GSTM1—hematologic cancer	5.95e-06	0.000127	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CDKN2B—hematologic cancer	5.95e-06	0.000127	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.94e-06	0.000127	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.91e-06	0.000126	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—SDC1—hematologic cancer	5.9e-06	0.000126	CbGpPWpGaD
Piroxicam—ALB—Metabolism—SDC1—hematologic cancer	5.87e-06	0.000125	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CYCS—hematologic cancer	5.83e-06	0.000124	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PIK3R1—hematologic cancer	5.81e-06	0.000124	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—HSP90AA1—hematologic cancer	5.8e-06	0.000123	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.79e-06	0.000123	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.79e-06	0.000123	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD86—hematologic cancer	5.75e-06	0.000122	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HES1—hematologic cancer	5.67e-06	0.000121	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—JAK2—hematologic cancer	5.65e-06	0.00012	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ALOX5—hematologic cancer	5.65e-06	0.00012	CbGpPWpGaD
Piroxicam—PTGS2—Disease—NCOR1—hematologic cancer	5.64e-06	0.00012	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.63e-06	0.00012	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.62e-06	0.00012	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.6e-06	0.000119	CbGpPWpGaD
Piroxicam—PTGS2—Disease—FGF1—hematologic cancer	5.58e-06	0.000119	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.56e-06	0.000118	CbGpPWpGaD
Piroxicam—PTGS2—Disease—FOXO1—hematologic cancer	5.5e-06	0.000117	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PDGFRB—hematologic cancer	5.49e-06	0.000117	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—NUP98—hematologic cancer	5.47e-06	0.000116	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PDGFRA—hematologic cancer	5.4e-06	0.000115	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PRKCG—hematologic cancer	5.38e-06	0.000115	CbGpPWpGaD
Piroxicam—PTGS2—Disease—JAK1—hematologic cancer	5.38e-06	0.000115	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PIK3CB—hematologic cancer	5.36e-06	0.000114	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.32e-06	0.000113	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.31e-06	0.000113	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.31e-06	0.000113	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.29e-06	0.000113	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—NUP214—hematologic cancer	5.27e-06	0.000112	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—MTHFR—hematologic cancer	5.26e-06	0.000112	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.22e-06	0.000111	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.22e-06	0.000111	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	5.18e-06	0.00011	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—MTR—hematologic cancer	5.16e-06	0.00011	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.16e-06	0.00011	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GSTP1—hematologic cancer	5.14e-06	0.000109	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ENO2—hematologic cancer	5.06e-06	0.000108	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—NQO1—hematologic cancer	5.02e-06	0.000107	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CD44—hematologic cancer	5.02e-06	0.000107	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CD44—hematologic cancer	4.99e-06	0.000106	CbGpPWpGaD
Piroxicam—ALB—Metabolism—NQO1—hematologic cancer	4.99e-06	0.000106	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MTHFR—hematologic cancer	4.99e-06	0.000106	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.97e-06	0.000106	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TERT—hematologic cancer	4.97e-06	0.000106	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HLA-A—hematologic cancer	4.97e-06	0.000106	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—IL2—hematologic cancer	4.93e-06	0.000105	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.91e-06	0.000105	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.91e-06	0.000105	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.88e-06	0.000104	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ABCB1—hematologic cancer	4.87e-06	0.000104	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PDGFB—hematologic cancer	4.85e-06	0.000103	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.84e-06	0.000103	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SDC1—hematologic cancer	4.8e-06	0.000102	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CYCS—hematologic cancer	4.75e-06	0.000101	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TSC2—hematologic cancer	4.74e-06	0.000101	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—NCOR1—hematologic cancer	4.72e-06	0.000101	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—GSTM1—hematologic cancer	4.72e-06	0.000101	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CYCS—hematologic cancer	4.72e-06	0.0001	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.72e-06	0.0001	CbGpPWpGaD
Piroxicam—ALB—Metabolism—HSP90AA1—hematologic cancer	4.69e-06	9.98e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.63e-06	9.87e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.59e-06	9.76e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—FGFR3—hematologic cancer	4.56e-06	9.71e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.53e-06	9.64e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—EP300—hematologic cancer	4.42e-06	9.41e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PIK3CG—hematologic cancer	4.42e-06	9.41e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.33e-06	9.22e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—BAD—hematologic cancer	4.33e-06	9.21e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—SRC—hematologic cancer	4.3e-06	9.15e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—NOTCH1—hematologic cancer	4.28e-06	9.12e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.24e-06	9.04e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.22e-06	8.98e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD80—hematologic cancer	4.2e-06	8.93e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—KIT—hematologic cancer	4.19e-06	8.92e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—VEGFA—hematologic cancer	4.19e-06	8.91e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.18e-06	8.91e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—MTHFR—hematologic cancer	4.18e-06	8.89e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GSTP1—hematologic cancer	4.16e-06	8.86e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—NRAS—hematologic cancer	4.14e-06	8.8e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PTPN11—hematologic cancer	4.12e-06	8.76e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CREBBP—hematologic cancer	4.1e-06	8.72e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—NQO1—hematologic cancer	4.08e-06	8.69e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CD44—hematologic cancer	4.08e-06	8.69e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.05e-06	8.62e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.02e-06	8.57e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4e-06	8.51e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CREB1—hematologic cancer	3.99e-06	8.49e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—MAPK3—hematologic cancer	3.96e-06	8.43e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.96e-06	8.43e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—BRAF—hematologic cancer	3.94e-06	8.38e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ABCB1—hematologic cancer	3.94e-06	8.38e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—IL6R—hematologic cancer	3.89e-06	8.28e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.88e-06	8.27e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CREBBP—hematologic cancer	3.88e-06	8.27e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CYCS—hematologic cancer	3.86e-06	8.22e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.84e-06	8.18e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.84e-06	8.18e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TGFB1—hematologic cancer	3.84e-06	8.18e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.84e-06	8.17e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ALB—hematologic cancer	3.83e-06	8.16e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—GSTM1—hematologic cancer	3.82e-06	8.14e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—NCOR1—hematologic cancer	3.82e-06	8.14e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MAP2K1—hematologic cancer	3.71e-06	7.89e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PIK3CD—hematologic cancer	3.68e-06	7.84e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.68e-06	7.83e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.67e-06	7.81e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—KRAS—hematologic cancer	3.56e-06	7.58e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—FGF2—hematologic cancer	3.53e-06	7.51e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PIK3CG—hematologic cancer	3.51e-06	7.47e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PIK3R1—hematologic cancer	3.48e-06	7.4e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.45e-06	7.35e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.4e-06	7.25e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.4e-06	7.23e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PIK3CB—hematologic cancer	3.39e-06	7.21e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—JAK2—hematologic cancer	3.38e-06	7.2e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—MTHFR—hematologic cancer	3.38e-06	7.19e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MDM2—hematologic cancer	3.3e-06	7.02e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.29e-06	7.01e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—PIK3CA—hematologic cancer	3.27e-06	6.96e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CREBBP—hematologic cancer	3.25e-06	6.92e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.22e-06	6.86e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MTOR—hematologic cancer	3.21e-06	6.83e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PIK3CB—hematologic cancer	3.21e-06	6.83e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CD4—hematologic cancer	3.2e-06	6.82e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—TP53—hematologic cancer	3.16e-06	6.73e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.13e-06	6.66e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.13e-06	6.66e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PIK3CD—hematologic cancer	3.08e-06	6.57e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ALB—hematologic cancer	3.04e-06	6.48e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—HRAS—hematologic cancer	3.03e-06	6.44e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CDKN1B—hematologic cancer	3.01e-06	6.41e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.99e-06	6.37e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.98e-06	6.34e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PTEN—hematologic cancer	2.93e-06	6.23e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PIK3R1—hematologic cancer	2.91e-06	6.2e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.85e-06	6.08e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PIK3CG—hematologic cancer	2.84e-06	6.04e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—EP300—hematologic cancer	2.79e-06	5.94e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CDKN1A—hematologic cancer	2.78e-06	5.92e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PTEN—hematologic cancer	2.77e-06	5.91e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.76e-06	5.89e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PIK3CB—hematologic cancer	2.69e-06	5.72e-05	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—AKT1—hematologic cancer	2.67e-06	5.69e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.65e-06	5.63e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—EP300—hematologic cancer	2.65e-06	5.63e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CREBBP—hematologic cancer	2.63e-06	5.6e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—SRC—hematologic cancer	2.57e-06	5.48e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.51e-06	5.34e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PIK3CD—hematologic cancer	2.5e-06	5.31e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—STAT3—hematologic cancer	2.48e-06	5.28e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ALB—hematologic cancer	2.48e-06	5.27e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—NRAS—hematologic cancer	2.47e-06	5.27e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.44e-06	5.19e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MAPK3—hematologic cancer	2.37e-06	5.05e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.37e-06	5.04e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PIK3R1—hematologic cancer	2.36e-06	5.02e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.32e-06	4.95e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PTEN—hematologic cancer	2.32e-06	4.95e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—MYC—hematologic cancer	2.3e-06	4.91e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TGFB1—hematologic cancer	2.3e-06	4.9e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—EP300—hematologic cancer	2.22e-06	4.72e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.19e-06	4.66e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PIK3CB—hematologic cancer	2.17e-06	4.63e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.15e-06	4.59e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—KRAS—hematologic cancer	2.13e-06	4.53e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.06e-06	4.39e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.04e-06	4.35e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ALB—hematologic cancer	2.02e-06	4.29e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—PIK3CA—hematologic cancer	1.96e-06	4.17e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.93e-06	4.11e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PTEN—hematologic cancer	1.89e-06	4.02e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PTEN—hematologic cancer	1.88e-06	4e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—HRAS—hematologic cancer	1.81e-06	3.85e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—EP300—hematologic cancer	1.8e-06	3.84e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—EP300—hematologic cancer	1.79e-06	3.82e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.78e-06	3.79e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—IL6—hematologic cancer	1.73e-06	3.69e-05	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—AKT1—hematologic cancer	1.69e-06	3.59e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.64e-06	3.49e-05	CbGpPWpGaD
Piroxicam—PTGS2—Disease—AKT1—hematologic cancer	1.6e-06	3.4e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PTEN—hematologic cancer	1.54e-06	3.27e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—EP300—hematologic cancer	1.47e-06	3.12e-05	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—AKT1—hematologic cancer	1.34e-06	2.85e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.33e-06	2.84e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—PIK3CA—hematologic cancer	1.33e-06	2.82e-05	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—AKT1—hematologic cancer	1.09e-06	2.32e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.09e-06	2.31e-05	CbGpPWpGaD
Piroxicam—ALB—Metabolism—AKT1—hematologic cancer	1.08e-06	2.31e-05	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—AKT1—hematologic cancer	8.86e-07	1.89e-05	CbGpPWpGaD
